PHARMACOKINETICS AND TISSUE PENETRATION OF RUFLOXACIN, A LONG-ACTING QUINOLONE ANTIMICROBIAL AGENT

被引:31
|
作者
WISE, R [1 ]
JOHNSON, J [1 ]
OSULLIVAN, N [1 ]
ANDREWS, JM [1 ]
IMBIMBO, BP [1 ]
机构
[1] MEDIOLANUM FARMACEUT,MILAN,ITALY
关键词
D O I
10.1093/jac/28.6.905
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The pharmacokinetics of rufloxacin after a single 400 mg oral dose were studied in eight volunteers, measuring plasma, inflammatory fluid and urine concentrations. Mean peak plasma concentrations of 4-4 mgL were achieved at a mean time of 1-9 h after administration. The mean plasma elimination half-life was 28-2 h. Mean peak levels in inflammatory fluid reached 3-2 mgL after 3-5 h, and 30-7 of the dose was eliminated in urine by 96 h. The apparent mean volume of distribution of rufloxacin, at steady state, was 109-5 L. The mean percentage penetration of rufloxacin into the inflammatory exudate, as measured by ratios of AUQ JO h was 90. © 1991 by The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:905 / 909
页数:5
相关论文
共 50 条
  • [1] DURATION OF TREATMENT WITH A LONG-ACTING QUINOLONE
    RIMOLDI, R
    CAZZOLA, M
    COGO, R
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 60 - 61
  • [2] Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy
    Gautam, Nagsen
    Roy, Upal
    Balkundi, Shantanu
    Puligujja, Pavan
    Guo, Dongwei
    Smith, Nathan
    Liu, Xin-Ming
    Lamberty, Benjamin
    Morsey, Brenda
    Fox, Howard S.
    McMillan, JoEllyn
    Gendelman, Howard E.
    Alnouti, Yazen
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) : 3110 - 3120
  • [3] PHARMACOKINETICS OF LONG-ACTING OXYTETRACYCLINE IN THE RAT
    CURL, JL
    CURL, JS
    HARRISON, JK
    LABORATORY ANIMAL SCIENCE, 1986, 36 (05): : 585 - 586
  • [4] The Pharmacokinetics of Long-Acting Antipsychotic Medications
    Spanarello, Stefano
    La Ferla, Teresa
    CURRENT CLINICAL PHARMACOLOGY, 2014, 9 (03): : 310 - 317
  • [5] PHARMACOKINETICS OF LONG-ACTING THEOPHYLLINE DRUGS
    SPANGLER, DL
    BLOOM, FL
    WITTIG, HJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1976, 57 (03) : 249 - 249
  • [6] REDUCTION IN SNORING WITH PHOSPHOCHOLINAMIN, A LONG-ACTING TISSUE-LUBRICATING AGENT
    HOFFSTEIN, V
    MATEIKO, S
    HALKO, S
    TAYLOR, R
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 1987, 8 (04) : 236 - 240
  • [7] IVERMECTIN - A LONG-ACTING MICROFILARICIDAL AGENT
    ETTE, EI
    THOMAS, WOA
    ACHUMBA, JI
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1990, 24 (04): : 426 - 433
  • [8] A new long-acting anticholinergic agent
    Lopez-Vidriero, M
    REVUE DES MALADIES RESPIRATOIRES, 1998, 15 : S55 - S56
  • [9] Pharmacokinetics and milk penetration of difloxacin after a long-acting formulation for subcutaneous administration to lactating goats
    Marin, P.
    Escudero, E.
    Fernandez-Varon, E.
    Ramirez, M. J.
    Carceles, C. M.
    JOURNAL OF DAIRY SCIENCE, 2010, 93 (07) : 3056 - 3064
  • [10] PHARMACOKINETICS OF BENZODIAZEPINES - SHORT-ACTING VERSUS LONG-ACTING
    BREIMER, DD
    JOCHEMSEN, R
    VONALBERT, HH
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1980, 30-1 (NA5): : 875 - 881